Filing Details
- Accession Number:
- 0001127602-23-014089
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-02 16:19:48
- Reporting Period:
- 2023-04-28
- Accepted Time:
- 2023-05-02 16:19:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238334 | S Daniel Jonas | C/O Conmed Corp 11311 Concept Boulevard Largo FL 33773 | Special Counsel & Corp Secy | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-04-28 | 626 | $0.00 | 13,462 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2023-04-28 | 10,000 | $97.69 | 23,462 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-04-28 | 5,500 | $125.57 | 17,962 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 4,300 | $126.72 | 13,662 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-04-28 | 200 | $127.56 | 13,462 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2023-04-28 | 10,000 | $0.00 | 10,000 | $97.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2030-03-02 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder,
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Billionaire Hedge Funds
